OUR GOAL: SAFE INJECTIONS FOR EVERYONE
Last year, 60 billion injections of vaccines and medicines were given to patients around the world – and most came from multi-dose vials.
But multi-dose vials and reused syringes in clinical settings cause at least 1.3 million deaths each year - and more than 20 million new Hepatitis B cases and other terrible diseases.
Multi-dose vials also reduce equity and access when compared to single-dose presentations. Yet multi-dose vials make up over 90% of UNICEF vaccine purchases because of their low price.
Finally, there is a better way.
APIJECT: AN ULTRA-LOW-COST SOLUTION
ApiJect is a compact, prefilled, single-dose “soft” syringe - manufactured using Blow-Fill-Seal (BFS) technology.
Its simple design means any healthcare worker can use it. Being prefilled and single-dose makes it a leader in safety. And, BFS enables rapid manufacturing at enormous scale.
Put together: ApiJect outperforms multi-dose glass vials on safety, access, equity and cost.
BLOW-FILL-SEAL CHANGES THE GAME
Every year, 50 billion bottles of eye drops, ear drops, nose sprays and vaccines are sold in squeezable plastic bottles that are manufactured using BFS.
ApiJect’s technology makes it possible to bring the advantages of BFS to injectable vaccines and medicines. BFS machines can make 34,000 ApiJect devices an hour, at a lower per-dose delivery cost than that of a 10-dose vial.
In addition, BFS soft syringes can be manufactured in any custom shape.
FOUNDED TO TRANSFORM THE WORLD
ApiJect was conceived by Marc Koska to eliminate unsafe injections in healthcare settings around the world. Every year, billions of unsafe medical injections kill 1.3 million people, while infecting another 20 million – mostly women and children.
ApiJect’s mission is to replace all of the reusable syringes and multi-dose vials worldwide to ensure no one is ever infected by a contaminated syringe.
See how ApiJect soft syringes will revolutionize
medicine and vaccine injections worldwide.